Actor Dave Coulier, best known for his role in the sitcom “Full House,” recently sat down with CURE to discuss facing cancer ...

Misconceptions about lung cancer, such as the stigma of smoking, are addressed, highlighting that anyone with lungs can ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

“PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of ...

Sluga, a testicular cancer survivor, has been a contributing blogger for CURE ’s website, curetoday.com, since January 2024, ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to GSK’227, now known as risvutatug rezetecan ...

Jace Yawnick, now in remission from non-Hodgkin lymphoma, is navigating the world of mental health one day at a time. Jace Yawnick, now 27-years-old and in remission from non-Hodgkin lymphoma, is ...

At the 2025 ASH Annual Meeting and Exposition, researchers presented new findings that may meaningfully affect how patients ...

Gastric cancer treatment can be especially challenging because patients often struggle with eating, maintaining weight, and ...

The SHARON trial is a phase 1 study testing a new treatment called GO-4 for patients with advanced pancreatic cancer who have ...

Living with chronic cancer involves balancing health precautions with the desire to enjoy life, especially during the ...

Treatment with bleximenib and Venclexta (venetoclax) showed a tolerable safety profile in a phase 1b trial for patients with ...